Based on the profit upgrade, JP Morgan have upgraded their price target to 91c. That's a long way from the 55c where it sits at the moment!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025